Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00021996 · ClinicalTrials.gov registry record · NA
Valdecoxib in Treating Chronic Pain in Cancer Patients
A NA study, sponsored by Dana-Farber Cancer Institute.
- Completed
- Registry status
- NA
- Development phase
NCT00021996 is a NA study that has completed, run by Dana-Farber Cancer Institute.
The verdict
NCT00021996, a NA study, has completed, sponsored by Dana-Farber Cancer Institute.
- COMPLETED
- Registry status
- NA
- Development phase
Study Summary
RATIONALE: Valdecoxib may be effective in relieving chronic pain in cancer patients. It is not yet known if valdecoxib is effective in treating chronic pain. PURPOSE: Randomized clinical trial to study the effectiveness of valdecoxib in relieving chronic pain in cancer patients.
Interventions
- DRUG valdecoxib
Trial Details
| Field | Value |
|---|---|
| Start Date | 2001-01 |
| Est. Completion | 2004-02 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00021996
The ClinicalTrials.gov registry entry for NCT00021996 describes a study currently listed as completed, categorized as NA. An enrollment target was not published in the registry record, which is common for early-stage or observational entries. The listed sponsor is Dana-Farber Cancer Institute, which has 781 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which valdecoxib is the first listed.
NCT00021996 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00021996 about?
NCT00021996 is a clinical study titled "Valdecoxib in Treating Chronic Pain in Cancer Patients". RATIONALE: Valdecoxib may be effective in relieving chronic pain in cancer patients. It is not yet known if valdecoxib is effective in treating chronic pain. PURPOSE: Randomized clinical trial to study the effectiveness of valdecoxib in relieving chronic pain in cancer patients.
What is the current status of trial NCT00021996?
This trial is currently completed. It is a NA study. The study started on 2001-01. Estimated completion is 2004-02.
What interventions are being tested in trial NCT00021996?
The interventions under investigation include: valdecoxib (DRUG).
Who is sponsoring clinical trial NCT00021996?
This trial is sponsored by Dana-Farber Cancer Institute, which has 781 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.